Company: Be Biopharma
Job title: CEO
Panel Discussion: Navigating the Catch-22 With GBM Funding: How Can Investors & Companies Work Together to Solve This Dilemma?
Moderated by: Scott Rakestraw 9:30 am
Unpacking what is holding back pharma from pursuing collaborations in this space Addressing how to attract investment for the indication that the proposition has not yet been clinically proven Discussing gaining support for novel strategies, including combination trials especially when monotherapy has not been proven in isolation Evaluating preclinical models in their reliability to reflect…Read more
day: Conference Day Two